Simon R Johnson Selected Research

lipoarabinomannan (LAM)

4/2022	A survey of use of mTOR inhibitors in patients with lymphangioleiomyomatosis listed for lung transplant.
1/2022	Cross talk between LAM cells and fibroblasts may influence alveolar epithelial cell behavior in lymphangioleiomyomatosis.
11/2021	Lymphangioleiomyomatosis: pathogenesis, clinical features, diagnosis, and management.
1/2021	Histamine signaling and metabolism identify potential biomarkers and therapies for lymphangioleiomyomatosis.
1/2021	Mast-Cell Tryptase Release Contributes to Disease Progression in Lymphangioleiomyomatosis.
1/2021	Machine learning can predict disease manifestations and outcomes in lymphangioleiomyomatosis.
10/2020	Pregnancy in lymphangioleiomyomatosis: clinical and lung function outcomes in two national cohorts.
1/2020	Evolution of lung pathology in lymphangioleiomyomatosis: associations with disease course and treatment response.
1/2020	Sphingolipid, fatty acid and phospholipid metabolites are associated with disease severity and mTOR inhibition in lymphangioleiomyomatosis.
10/2019	Cross-sectional study of reversible airway obstruction in LAM: better evidence is needed for bronchodilator and inhaled steroid use.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Simon R Johnson Research Topics

Disease

34	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 04/2022 - 04/2002
16	Tuberous Sclerosis (Bourneville's Disease) 01/2022 - 04/2002
9	Lung Diseases (Lung Disease) 01/2022 - 02/2007
9	Cysts 01/2021 - 04/2002
9	Angiomyolipoma 01/2021 - 04/2002
8	Rare Diseases (Rare Disease) 12/2018 - 04/2002
8	Chronic Obstructive Pulmonary Disease (COPD) 12/2018 - 06/2008
7	Asthma (Bronchial Asthma) 01/2022 - 08/2004
7	Pneumothorax 01/2021 - 04/2002
6	Respiratory Insufficiency (Respiratory Failure) 11/2021 - 07/2010
5	Neoplasms (Cancer) 11/2021 - 04/2002
3	Disease Progression 01/2021 - 06/2015
2	Idiopathic Pulmonary Fibrosis 01/2022 - 01/2018
2	Airway Remodeling 01/2022 - 08/2004
2	Lymphatic Abnormalities 01/2020 - 10/2014
2	Nausea 01/2018 - 02/2007
2	Inborn Genetic Diseases (Disease, Hereditary) 11/2016 - 03/2016
2	Fatigue 05/2009 - 02/2007
1	COVID-19 01/2022
1	Eosinophilia 01/2021
1	Carcinogenesis 01/2021
1	Airway Obstruction (Choking) 10/2019
1	Rupture 12/2018
1	Menstruation Disturbances 01/2018
1	Acne Vulgaris 01/2018
1	Ulcer 01/2018
1	Breast Neoplasms (Breast Cancer) 02/2016
1	Lung Injury 01/2016
1	Fibrosis (Cirrhosis) 01/2016
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2016
1	Inflammation (Inflammations) 01/2015
1	Hemorrhage 10/2014
1	Lymphatic Diseases 04/2012
1	Interstitial Lung Diseases (Interstitial Lung Disease) 03/2012
1	Emphysema 11/2011
1	Spontaneous Abortion (Miscarriage) 05/2009
1	Premature Birth (Birth, Premature) 05/2009

Drug/Important Bio-Agent (IBA)

30	lipoarabinomannan (LAM)IBA 04/2022 - 04/2002
12	trans-sodium crocetinate (crocetin)IBA 11/2021 - 04/2002
9	Proteins (Proteins, Gene)FDA Link 01/2020 - 04/2002
8	Sirolimus (Rapamycin)FDA Link 01/2022 - 01/2008
8	Matrix Metalloproteinases (MMPs)IBA 01/2019 - 08/2004
5	Peptide Hydrolases (Proteases)FDA Link 12/2018 - 01/2010
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 04/2012
3	CollagenIBA 01/2022 - 01/2014
3	Doxycycline (Periostat)FDA LinkGeneric 05/2014 - 09/2010
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2022 - 01/2016
2	EnzymesIBA 01/2019 - 06/2008
2	Protease Inhibitors (Protease Inhibitor)IBA 12/2018 - 01/2010
2	Pancreatic Elastase (Elastase)IBA 12/2018 - 06/2008
2	Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA 01/2017 - 01/2014
2	TOR Serine-Threonine KinasesIBA 08/2010 - 01/2007
1	MTOR InhibitorsIBA 04/2022
1	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 01/2022
1	OvalbuminIBA 01/2022
1	rasagiline (Azilect)FDA Link 01/2021
1	Interleukin-33IBA 01/2021
1	Clorgyline (Clorgiline)IBA 01/2021
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2021
1	Histidine (L-Histidine)FDA Link 01/2021
1	Oxidoreductases (Dehydrogenase)IBA 01/2021
1	Histamine H1 Receptors (Histamine H1 Receptor)IBA 01/2021
1	Loratadine (Alavert)FDA Link 01/2021
1	Tryptases (Tryptase)IBA 01/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2020
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2020
1	SphingolipidsIBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Protein Isoforms (Isoforms)IBA 01/2020
1	SteroidsIBA 10/2019
1	Bronchodilator Agents (Bronchodilators)IBA 10/2019
1	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2019
1	DefensinsIBA 12/2018
1	AminesIBA 12/2018
1	Complement System Proteins (Complement)IBA 12/2018
1	MucinsIBA 12/2018
1	Vitamin D-Binding ProteinIBA 11/2018
1	Cathepsin KIBA 08/2017
1	Methacholine Chloride (Methacholine)FDA Link 01/2017
1	Metalloproteases (Metalloproteinases)IBA 02/2016
1	GelatinIBA 01/2016
1	Hydroxyproline (4 Hydroxyproline)IBA 01/2016
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2016
1	Secretory Leukocyte Peptidase InhibitorIBA 01/2016
1	Simvastatin (Zocor)FDA LinkGeneric 01/2015
1	TenascinIBA 01/2014
1	Vascular Endothelial Growth Factor DIBA 04/2012
1	Certolizumab Pegol FDA Link 03/2012
1	Mechanistic Target of Rapamycin Complex 1IBA 06/2011
1	plerixafor FDA Link 08/2010
1	platelet-derived growth factor C (PDGF-C)IBA 03/2009
1	GelatinasesIBA 06/2008
1	ImmunosorbentsIBA 06/2008
1	Collagenases (Collagenase)FDA Link 06/2008
1	Biotin (Vitamin H)FDA Link 06/2008

Therapy/Procedure

11	Therapeutics 01/2022 - 01/2008
3	Lung Transplantation 04/2022 - 07/2010
1	Pleurodesis 11/2017
1	Nephrectomy 10/2014
1	Transplantation 07/2010